June 21, 2025: Oil traders remain uncertain amid ongoing geopolitical tensions following Trump's mixed signals regarding Iran. The US stock market displays mild fluctuations as investors await Federal Reserve Chair Jerome Powell's remarks on inflation. Meanwhile, a Chinese biotech firm introduces a competitor to Eli Lilly's obesity treatment, potentially impacting the pharmaceutical sector. Distress in commercial real estate continues to escalate, raising concerns among investors. Additionally, discussions around home equity and consumer spending trends emerge as key topics. Stay tuned for insights on these developments. Powered by LabCat AI research tools.